All women diagnosed with invasive epithelial ovarian cancer should be offered genetic testing for BRCA mutations to inform their treatment decisions and also to provide risk management advice for family members, a new position statement from Cancer Australia recommends. The position statement reflects the “mainstreaming” of genetic testing and the fact that BRCA1 and BRCA2 ...
Genetic testing now recommended for all women with ovarian cancer
By Michael Woodhead
1 Feb 2018